To evaluate a combination of topographyguided custom ablation and corneal collagen crosslinking (CXL) in a single procedure for the treatment of keratectasia.
METHODS:
Twelve eyes of 12 patients with keratectasia were treated with topography-guided custom ablation and CXL. Topography-guided custom ablation was performed using a transepithelial technique with the iVIS Suite 1 kHz fl ying spot excimer laser. Collagen cross-linking was performed immediately after topography-guided custom ablation, according to standard protocol. Postoperative follow-up examinations were performed at 1, 3, 6, and 12 months. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refractive change, corneal topography, and pachymetry were analyzed pre-and postoperatively. K eratectasia is often accompanied by visually disturbing irregular astigmatism, which leads to serious deterioration of vision. Traditionally, it has been treated by invasive procedures such as corneal transplantation 1 and, to some extent, by implantation of intracorneal ring segments. 2 A combination of topography-guided custom ablation-to improve vision-and corneal collagen cross-linking (CXL)-to make that visual improvement last-was fi rst attempted by Kanellopoulos and Binder. 3 However, they applied CXL fi rst and did not perform topography-guided custom ablation until 12 months later. The current study describes a combined procedure where topography-guided custom ablation is performed fi rst, immediately followed by CXL.
PATIENTS AND METHODS
Twelve eyes of 12 patients (8 men, 4 women) were treated with topography-guided custom ablation and CXL at the University Hospital of North Norway, Tromsø, Norway. Mean patient age was 39.8Ϯ11.9 years (range: 26 to 62 years). Six cases were diagnosed as keratoconus and 6 as pellucid marginal degeneration. The inclusion criteria were diagnosis of keratectasia, best spectacle-corrected visual acuity (BSCVA) worse than 20/30 that could not be further improved by use of soft contact lenses, and no previous eye surgery. Exclusion criteria were corneal thickness Ͻ400 µm; keratometric readings Ͼ60.00 diopters (D); other active ocular disease; patients who were immunocompromised, pregnant, or who had atopic syndrome; known sensitivity to study medication; Custom Ablation and CXL for Keratectasia/Stojanovic et al intraocular pressure Ͼ23 mmHg; history of glaucoma; or glaucoma suspects. The study was approved by the regional ethics committee, and patients signed informed consent concerning the new combined treatment.
Preoperative examination consisted of slit-lamp microscopy, Scheimpfl ug-based corneal topography/ tomography (Precisio; Ligi, Taranto, Italy), visual acuity/manifest refraction (NIDEK RT 2100 system; NIDEK Co Ltd, Aichi, Japan), dynamic pupillometry (pMetrics, Ligi), Goldmann applanation tonometry, and central ultrasound pachymetry (Corneo-Gage Plus; Sonogage Inc, Cleveland, Ohio). Precisio was used for measurement of 1) anterior corneal elevation (used for topography-guided custom ablation), 2) keratometric asymmetry within the central 3 mm (for assessment of the corneal optical irregularity), and 3) maximum posterior corneal surface elevation above the fl oating bestfi t sphere fi tted at a 10-mm diameter (for assessment of corneal biomechanical stability).
A procedure consisting of transepithelial topographyguided custom ablation followed immediately by CXL (in the same session) was performed. Topography-guided custom ablation was performed using iVIS Suite (Ligi), which consists of the iRES laser, Scheimpfl ugtopographer/tomographer, dynamic pupillometer, and Corneal Interactive Programmed Topographic Ablation (CIPTA) software. With the iVIS topography-guided custom ablation system, the patient's refraction, corneal elevation data, and pupillometry data are imported into CIPTA software, which then compiles an ablation that transforms the actual corneal shape into a regularized aspheric shape of a desired curvature within a desired treatment zone. The CIPTA software fully customizes the ablation including parameters such as tilt, centration, and asphericity of the targeted corneal surface, as well as the size and shape of the optical and transition zones.
Maximum ablation depth was 60 µm, whereas the minimal postoperative corneal thickness was 400 µm. To optimize the visual outcome under these constraints, the CIPTA "restored morphological axis" and "minimal ablation" strategies were used. The mechanism of action of the former is described elsewhere. 4 In the minimal ablation strategy, the software suggests a curvature change that results in maximal reduction of the irregularities with the least possible amount of tissue consumption.
The CIPTA-generated ablation plan is transferred to the high-resolution, 0.6-mm dual fl ying-spot iRES excimer laser, which delivers an effective frequency of up to 1 kHz (2ϫϽ500 Hz) and employs a high-speed eye-tracking system with dynamic intraoperative cyclotorsional compensation based on iris recognition.
In addition to its constant frequency per area delivery, the laser's fl uence and shot pattern are optimized to minimize the ablation rate difference between corneal epithelium and stroma, making the transepithelial treatment the system's recommended surgical technique. 4 Transepithelial treatment consists of two parts: a lamellar ablation for epithelial removal, and a custom ablation for corneal stromal regularization to a desired curvature and toricity. In practice, these two ablations are summed and executed as a single continuous ablation.
Surgical protocol describing the use of medication before and during the excimer laser treatment is described elsewhere. 5 Immediately after the ablation, the pachymetric measurements were taken and the stroma was saturated by topically applied 0.1% ribofl avin-5-phosphate and 20% dextran solution, as one drop every 3 minutes. In cases where the measurements of the minimal corneal thickness showed values Ͻ400 µm, hypotonic 0.1% ribofl avin solution was applied until slight corneal edema and 400-µm thickness were achieved. After the corneal saturation was confi rmed by presence of fl uorescent fl are in the anterior chamber, the cornea was irradiated by ultraviolet A (UVA) light for 30 minutes. A timer controlled UVA-illuminator (UV-X; IROC, Zurich, Switzerland) provided a homogeneous UVA (365 nm) light with 3 mW/cm 2 power within a circle of 9 mm in diameter. After the irradiation, non-preserved chloramphenicol (Novartis, Basel, Switzerland) eye drops were applied, as well as a bandage contact lens (Acuvue Oasys; Johnson & Johnson Vision Care Inc, Jacksonville, Fla), which was worn for 4 to 7 days. Dexamethasone with chloramphenicol (Novartis) eye drops were used four times daily for the fi rst 2 weeks, and then replaced by a low potency steroid rimexolone 1% (Vexol; Alcon Laboratories Inc, Ft Worth, Tex) three times daily for another 2 weeks, and twice daily for the last 2 weeks. Valium 5 mg before sleep was prescribed for the fi rst 3 days. Chilled 0.2% hyaluronic acid (for lubrication and lavage purposes) was used every 10 minutes for the remainder of the day after surgery and later as needed. Patients were seen on postoperative day 4 to 7 (upon bandage contact lens removal) and 1, 3, 6, and 12 months after surgery.
To calculate visual acuity averages and changes, all visual acuity measurements were converted from Snellen values to the logarithm of the minimum angle of resolution (logMAR) back to Snellen values. Vector analysis was used to analyze the changes of spherocylinders according to the Alpins' method. 6 The refractive outcome of astigmatism was represented as magnitude of error and angle of error. Figure 1 is a scattergram of attempted versus achieved spherical equivalent refraction, whereas a polar diagram shows the vector analysis of astigmatism correction (Fig 2) . The Table shows preoperative and 12-month postoperative data for all 12 patients. None of the eyes lost lines of BSCVA, whereas 10 eyes gained 1 to 4 lines (Fig 3) . Safety index was 1.60. Stability of spherical equivalent refraction is shown in Figure 4 . In 4 (33%) of 12 eyes, spherical equivalent refraction changed у1.00 D (P=.00). The increase of the posterior fl oat elevation within the follow-up time was within 11 µm, confi rming no progression of ectasia.
RESULTS

Mean
There were no complications other than bandage contact lens loss on postoperative day 1 in three cases, with consequent pain. No postoperative haze graded higher than 1 was observed at any of the follow-up examinations. Figures 5 to 10 show preoperative anterior and posterior elevation maps, pachymetry and curvature maps, as well as postoperative curvature maps of patients 1 and 2.
DISCUSSION
Corneal transplantation for keratectasia is a diffi cult procedure with a long and uncertain visual recovery. 7 The idea of an alternative treatment with a chance to postpone or replace transplantation and improve vision was appealing to the patients in the current study and they expressed a strong motivation for the new combined procedure presented herein.
Corneal collagen cross-linking has been clinically available for a number of years. 8, 9 It stiffens the stroma and halts the ectatic process, but it does not directly address the patient's refractive error. The spherocylindrical change that it causes is limited, ranging typically from a slight steepening to approximately 2.00 D of fl attening, 8 varying seemingly unpredictably from case to case. Excimer laser correction of the refractive errors in keratectasia has been previously attempted with variable success concerning predictability and stability. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Topography-guided custom ablation seems to be a suitable treatment for regularizing visually disturb- ing irregular astigmatism 26 in non-ectatic corneas with suffi cient thickness, but it is commonly considered contraindicated in unstable corneas with keratectasia because of the danger of worsening of the corneal structural stability and its consequences, caused by tissue removal. Topography-guided custom ablation and CXL combines the benefi ts of both treatments with the potential for creating a safe and stable optical improvement of the irregular keratectatic cornea in a less invasive fashion than the currently available treatment options. In the study by Kanellopoulos and Binder, 3 performing laser ablation 12 months after CXL caused a reduction in strength in the ablation area by ablating the superfi cial (supposedly the most strengthened) part of the CXL-treated cornea. Therefore in the current study, the order was reversed and CXL was performed immediately after topography-guided custom ablation to strengthen the stroma at a uniform depth, before the ectatic process had a chance to progress. Another advantage of this single combined procedure compared to the sequential procedure of Kanellopoulos is that the patient avoids two deepithelializations. The risk of haze, which can occur after surface ablation due to keratocyte activation, 27 may be lower if the surface ablation is performed in close proximity to CXL, due to temporary keratocyte loss during the fi rst months after CXL. 28 This constitutes the third advantage of performing topography-guided custom ablation and CXL in a single procedure.
Performing laser ablation and CXL in a single pro- Custom Ablation and CXL for Keratectasia/Stojanovic et al cedure raises the question of distinguishing their individual effects on the refraction and ectatic process. The refractive effects on cases with keratectasia, when performed separately, have already been investigated for both laser ablation [10] [11] [12] [13] [14] [15] and CXL, 8 whereas the effect of CXL when performed immediately after the laser ablation requires extensive clinical studies. To date, only the surgeon's clinical judgment can be used to determine the safe depth of the laser ablation, which when followed by CXL, will not result in further ectasia. However, development of reliable and standardized measurements of corneal biomechanical properties can lead to more objective surgical planning.
Our results showed relatively good safety, effi cacy, and predictability, if the amount and type of preoperative error are taken into consideration. The change in spherical equivalent refraction between 6 and 12 months was statistically signifi cant; however, it did not change more than 1.00 D in nine cases. The change may be explained either by corneal structural changes, continuous epithelial remodeling, or even the patient's adaptation to the new optical conditions.
In the current study, transepithelial surface topography-guided custom ablation was chosen instead of traditional surface ablation to avoid potential custom ablation planning error due to epithelial remodeling, which is a common characteristic of irregular astigmatism 29 (eg, epithelial thinning over the cone in keratoconus). Mechanical or alcohol epithelial removal, used in traditional surface ablation, would in cases where epithelial remodeling has occurred, reveal an irregular stromal surface that would no longer match the preoperative corneal topography upon which the custom ablation had been planned, causing a potentially signifi cant ablation error. 26 The transepithelial approach circumvents such error by adding a lamellar component to the custom ablation thus translating the targeted corneal surface (calculated by topography-guided custom ablation software) below the lowest point of the epithelium. Additionally, with the custom transepithelial approach the area of epithelial removal corresponds directly to the area of the custom ablation, with a consequence that only the absolutely necessary amount of epithelium is removed. This is less invasive than traditional surface ablation and it shortens the reepithelialization time. 
